The Impact of Temozolomide and Lonafarnib on the Stemness Marker Expression of Glioblastoma Cells in Multicellular Spheroids

Researchers investigated how drug treatments impact stemness marker expression of glioblastoma multiforme (GBM) cells in multicellular tumor spheroid (MCTS) models.